|
|
|
|
|
Here it is, our newsletter, now being forged less frequently than British prime ministers.
|
Since my last email, we have (re-) launched our community events calendar and (first-) launched our jobs board. Help us out by telling everyone you know, or go ahead and add new listings yourself.
|
In case you missed it, check out Nancy Devlin and co's blog post from September about the 'wheelchair example' used in EQ-5D valuation studies; it's crying out for a discussion in the comments section.
|
And a reminder that the newsletter is still young and impressionable. If there's something you would (or wouldn't) like to see here, let me know by reply.
|
|
|
|
New on the blog
|
|
|
|
|
Abraham introduces a conference and travel vlog summary of the 2022 EuHEA meeting in Oslo, Norway.
|
|
|
|
|
|
The 100th HESG gets the vlog treatment, with an early career researcher's perspective on the meeting.
|
|
|
|
|
|
You can now promote jobs and events (for free) on the blog. Both are community resources, relying on input from you, dear reader.
|
|
|
|
|
|
Job openings
|
|
|
|
Dates for your diary
|
|
|
|
|
|
|
|
Other stuff worth your time
|
- A podcast from the Manchester Cancer Research Centre explores the value of early detection with Katherine Payne [50 mins]
- OHE has published a series of blog posts on the UK's new 'delinked' model to promote investment in new antibiotics [5 mins]
- Wired gives big pharma a bashing on drug prices and R&D costs [4 mins]
- Jonathan Stokes considers the politics (and economics) of pandemic response [3 mins]
|
|
|
|
|
|
Until next time. Vote aheblog.
|
|
  
|
|
|
